We show that reducing Sox11 levels in the Brca1-deficient mammary tumour (Brca1.3) has similar effects on proliferation, stem cell activity and expression of lineage markers to those observed in studies using embryonic mammary progenitor cells (eG2M5). Here, SOX11 is linked to breast cancer.